12/15/2022 The Ministry of Health of the Russian Federation issued a license for the drug "Dimolegin"
12/15/2022 The Ministry of Health of the Russian Federation issued a license for the drug "Dimolegin"
News
08 of Sept., 2022 – participation in the FACT-bridge 2022 Antithrombotic Therapy Forum.
D.G. Tovbin, D.N. Tarasov, A.N. Kovalenko made oral presentations from our company.
05/22/2022 - participation in the 5-th Russian conference MedChem-Russia 2021
Dmitry Shulga made an oral presentation. Dmitry Tovbin participated in the round table "Ways to Accelerate the Implementation of Innovative Pharmaceutical Developments into Practice".
09.05.2022 new article published in Journal of Biomolecular Structure and Dynamics
Investigation of the tight binding mechanism of a new anticoagulant DD217 to factor Xa by means of molecular docking and molecular dynamics
On 11/30/2021 at 16:00 at the Institute of Phenomenology of Physics of the Russian Academy of Sciences (Chernogolovka) the thesis of Tserkovnikova N.A. will be defended.
The topic of the dissertation is “Synthesis and study of the pharmacological activity of new factor Xa inhibitors”. We invite everyone to support an employee of our company!